This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Nimbus Saturn, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Byron Scott Delabarre: Innovator in HPK1 Antagonists
Introduction
Byron Scott Delabarre is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of HPK1 antagonists. With a total of 2 patents to his name, Delabarre's work is paving the way for advancements in the treatment of HPK1-mediated disorders.
Latest Patents
Delabarre's latest patents focus on HPK1 antagonists and their uses. The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders. This innovative approach has the potential to impact various medical applications significantly.
Career Highlights
Delabarre is currently associated with Nimbus Saturn, Inc., where he continues to push the boundaries of scientific research and innovation. His work is characterized by a commitment to developing effective treatments that address critical health issues.
Collaborations
Some of his notable coworkers include Neelu Kaila and Ian Linney. Their collaborative efforts contribute to the dynamic research environment at Nimbus Saturn, Inc.
Conclusion
Byron Scott Delabarre's contributions to the field of biochemistry, particularly through his patents on HPK1 antagonists, highlight his role as an influential inventor. His ongoing work promises to lead to significant advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile